January 12, 2018 / 12:06 AM / 10 months ago

BRIEF-Integral Diagnostics Sees FY Normalised NPAT Growth Of Around 20 pct

Jan 12 (Reuters) - Integral Diagnostics Ltd:

* ‍CAPITAL EXPENDITURE FOR FULL YEAR IS FORECAST AT $17M​

* EXPECTS ACHIEVEMENT OF FULL YEAR NORMALISED NPAT GROWTH OF AROUND 20% (BEFORE TAKEOVER RESPONSE COSTS AND TRANSACTION COSTS) Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below